Forward Pharma (FWP:NAS) and Sierra Oncology (SRRA:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 49.440800 57274157 1.3014 1.0854 51.70 -33.28
LEXEA Liberty Expedia Holdings Inc 39.820000 57274157 1.0045 0.8742 51.70 -33.28
SOHU Sohu.com Inc 33.870000 38900888 None 1.7553 35.07 29.54
PDLI PDL BioPharma Inc 2.900000 153812256 4.0845 0.5273 3.43 1.85
FWP Forward Pharma A/S 2.120000 47183999 1.6693 0.0852 28.75 0.96
SRRA Sierra Oncology Inc 1.890000 52454181 None 1.0466 1.91 0.46
OPHT Ophthotech Corp 2.630000 36188161 0.8297 2.5019 4.61 5.82
GURE Gulf Resources Inc 1.430000 46803791 28.6000 0.1777 4.46 4.41
VSAR Versartis Inc 1.550000 36069791 None 0.6756 2.25 2.10
EVK Ever-Glory International Group Inc 3.650000 14795992 4.3452 0.5205 4.25 1.70
TRMT Tremont Mortgage Trust 12.600000 3126439 None None 19.82 None
APWC Asia Pacific Wire & Cable Corp Ltd 2.450000 13819669 10.2083 0.2278 3.73 0.36
PTX Pernix Therapeutics Holdings Inc 2.380000 11873562 None None 2.76 -21.12
GIGM GigaMedia Ltd 2.520000 11052235 None 0.4636 5.77 5.77
TNXP Tonix Pharmaceuticals Holding Corp 3.196600 7830790 None 1.0559 3.26 0.23
PRSS CafePress Inc 1.330000 16950353 None 0.6274 1.47 1.47
VLRX Valeritas Holdings Inc 3.120000 7007782 None 2.0607 3.70 -1.43
ABAC Renmin Tianli Group Inc 2.500000 7983745 17.8571 0.2204 7.85 7.58
CYCC Cyclacel Pharmaceuticals Inc 1.469900 11997447 None 0.7518 2.17 0.96
RTTR Ritter Pharmaceuticals Inc 3.080000 4940652 None 1.0147 4.58 None
TOPS TOP Ships Inc 1.609900 8923617 None 0.1354 2.70 -8.95
CHFS CHF Solutions Inc 3.140000 4226251 None 0.8172 3.69 0.31
CREG China Recycling Energy Corp 1.564700 8310198 None 0.0635 5.81 -0.21
KBSF KBS Fashion Group Ltd 4.730000 1771132 None 0.1038 13.17 11.87
CHEK Check-Cap Ltd 4.050000 1609133 0.6027 1.1036 4.35 None

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

FWP:NAS Forward Pharma

http://www.forward-pharma.com
Forward Pharma has 12 employees and is headquartered in Denmark.
Forward Pharma A/S is a Danish biopharmaceutical company preparing to initiate a clinical trial using FP187, a proprietary formulation of dimethyl fumarate, or DMF, for the treatment of multiple sclerosis, or MS, patients.

SRRA:NAS Sierra Oncology

https://www.sierraoncology.com
Sierra Oncology has 57 employees and is headquartered in Canada.
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.